Needham & Company LLC Raises Hims & Hers Health (NYSE:HIMS) Price Target to $65.00
Hims & Hers Health (NYSE:HIMS – Free Report) had its price objective upped by Needham & Company LLC from $61.00 to $65.00 in a research report sent to investors on Wednesday morning, Marketbeat reports. The firm currently has a buy rating on the stock. Several other analysts have also commented on HIMS. Truist Financial cut […]
Hims & Hers Health (NYSE:HIMS – Free Report) had its price objective upped by Needham & Company LLC from $61.00 to $65.00 in a research report sent to investors on Wednesday morning, Marketbeat reports. The firm currently has a buy rating on the stock. Several other analysts have also commented on HIMS. Truist Financial cut […]
